Skip to main content
Premium Trial:

Request an Annual Quote

Migrations: Dec 5, 2008

Premium
CytRx announced that week that Joseph Rubinfeld, a member of the company’s board of directors, has accepted the additional responsibility of chief scientific advisor.
 
Rubinfeld was previously the vice president and director of research and development for Bristol-Myers’ international division. He was among the four co-founders of Amgen, and founded SuperGen, where he served as CEO, president, and chief scientific officer. 
 

 
BrainCells announced this week the appointment of David Thompson to its board of directors. 
 
Thompson’s 30-year career at Eli Lilly and its affiliates culminated in a stint as vice president of corporate strategy and business development. During his tenure at Eli Lilly, Thompson served as director of corporate new product planning and licensing, president, and general manager of Eli Lilly Canada; president and CEO of then-Lilly subsidiary IVAC Corporation; and vice president of pharmaceutical product management and licensing. He is currently executive chairman of Bayhill Therapeutics, and is a member of the board of directors for Anthera Pharmaceuticals
 

 
PerkinElmer last week announced that Achim von Leoprechting has been appointed vice president and general manager of cellular imaging and analysis solutions.   
 

Von Leoprechting was previously the European sales director for the company's bio-discovery business. He has been with PerkinElmer in a variety of technology, sales, and marketing leadership roles since PerkinElmer acquired his previous employer, Packard BioScience, in 2002.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.